Eurofins Fact Sheet August 2013

File Name: Eurofins Fact Sheet August 2013.
doc EDR: 1-C-IR-EXE-01171823 Last modified on: 27/08/2013 Last modified by: Sylvain Besson Page 1 of 1

Our Vision: To be the World Leader in the
bioanalytical testing market

Our Mission: To contribute to global health and
safety by providing our customers with high
quality laboratory and advisory services whilst
creating opportunities for our employees and
generating sustainable shareholder value

Our Values: Achievement of our Mission is
based on Eurofins "Core Values", which
commit us to Customer focus, Quality,
Competence & Team Spirit and Integrity

Revenues in m CAGR
16%

2008 2009 2010 2011 2012
EBITDA in m
CAGR
20%

2007 2008 2009 2011 2012
* Objective

Eurofins shares are listed on
NYSE Euronext Paris
(since IPO in October 1997)
ISIN FR0000038259, Reuters EUFI.PA,
Bloomberg ERF FP
Indices: SBF120, Next 150, Next Biotech, SRD,
Compartment A

Share price performance as of 26 July 2013
(158.5) vs. IPO (10/1997 at 1.83) +8,556%
(32% CAGR)

Contact and Addresses

Florian Heupel, Group Marketing
[email protected]
10A, Rue Henri M. Schnadt, L-2530,
Luxembourg
Tel +352 261 85 31

Pamela Antay, Investor Relations
[email protected]
Chausse de Malines 455
B- 1950 Kraainem (Brussels) Belgium
Tel +32 2 766 1620

Please refer to our on-line group directory for
laboratory contact information
http://www.eurofins.com/media/7854659/group_directory_march_201
3.pdf

EUROFINS FACT SHEET
Company Overview
Eurofins Scientific is an international life sciences company which provides a unique range
of analytical testing services to clients across multiple industries. The Group is the world
leader in food and pharmaceutical products testing. It is also number one in the world in the
field of environmental laboratory services and discovery pharmacology, and one of the
global market leaders in agroscience, genomics and central laboratory services.
Short History
Eurofins Scientific was founded in 1987 with 10 employees to market the SNIF-NMR

technology, a patented analytical method used to verify the origin and purity of several
types of food and beverages and identify sophisticated fraud not detectable by other
methods.
Today the Eurofins Group is a leading provider of analytical services with:
an international network of around 180 laboratories across 35 countries in Europe,
the USA, Asia-Pacific and South America
over 14,000 staff
a portfolio of over 100,000 reliable and validated analytical methods
more than 80 million assays performed each year to establish the safety, identity,
composition, authenticity, origin, traceability, and purity of biological substances and
products.
Eurofins is one of the fastest growing companies in Europe. Since its IPO on the French
stock exchange in 1997, Eurofins sales have increased by over 40% each year (in
compound average) to EUR 1.04 billion in 2012.
Between the Initial Public Offering on 24 October 1997 and 26 July 2013, Eurofins share
price has multiplied by 87x, an annual average increase of 32% (against 3% for the SBF
120, 2% for the CAC 40 and 6% for the Nasdaq over the same period).
Recent Developments
In 2012, Eurofins exceeded by almost 5% its EUR 1 billion revenue objective a full year
ahead of schedule. The early achievement of this objective reflects the benefits of both
past and ongoing investments to ensure the most comprehensive portfolio of analytical
methods and the most robust, state-of-the-art laboratory network that allows the Group to
provide the best analytical service to the markets it serves in the most efficient manner.
Having consistently invested more than any of its peers in the testing industry, Eurofins
boasts a very modern, streamlined network of laboratories uniquely capable of providing
high quality analyses at a reasonable cost.
In the 25 years since its foundation, Eurofins has embarked on two intense investment
phases. The first cycle (2000-2004) saw Eurofins expand its technological portfolio and
secure market leadership in Europe; the second cycle (2006-2010) expanded the Groups
geographical footprint and established the Group as the global reference in laboratory
testing of food, the environment and pharmaceutical products. Investments in start ups in
15 new countries, along with focused acquisitions, have substantially increased the range
of Eurofins offerings in its customers key markets around the world. Overall, the
laboratories started up by Eurofins in the last six years in new markets such as India,
China, Brazil, Singapore and Eastern Europe provide an increasingly important growth
engine for the Group.
Over the years, Eurofins has developed many new analytical testing methods and has
participated in, or led several R&D projects to find better ways to analyse food, the
environment and pharmaceuticals. Drawing on its world-class Competence Centres and
its expertise, Eurofins is driving growth from its market-leading portfolio of tests,
outsourcing agreements and through cross-selling opportunities across its world-wide
laboratory network.
Future Plans
Eurofins is committed to supporting its clients objectives of ensuring that their products
reach the best possible quality and safety levels in all markets in which they operate. The
Group intends to continue to develop and acquire the most comprehensive range of state-
of-the-art analytical technologies as well as expand its geographical reach in order to
support its clients increasingly stringent quality and safety standards and the expanding
demands of regulatory authorities around the world.
Eurofins has set an objective of doubling in size over the next five years to reach EUR 2bn
in revenues by 2017. Over this period, Eurofins plans to spend about EUR 500m in the
most modern laboratory network, analytical technology and IT systems to offer its clients
an ever expanding unmatched range of innovative, reliable and cost-effective testing
services.
80
59
93
139
161
1,044
633
640
680
829
2,000
2017*

Eurofins Fact Sheet August 2013

Uploaded by

Copyright:

Available Formats

Eurofins Fact Sheet August 2013

Uploaded by

Document Information

Original Description:

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Eurofins Fact Sheet August 2013

Uploaded by

Copyright:

Available Formats

File Name: Eurofins Fact Sheet August 2013.

You might also like